Confronta i metodi

	Questionario sulla Prontezza al Cambiamento (RCQ)	Brief Addiction Monitor (BAM)	Drug Use Disorders Identification Test (DUDIT)
Campo	Medicina delle dipendenze	Medicina delle dipendenze	Medicina delle dipendenze
Famiglia	Process / pipeline	Process / pipeline	Process / pipeline
Anno di origine	1992	2013	2005
Ideatore	Rollnick, Heather, Gold, Hall	Cacciola, Alterman, Drapkin, Valadez	Berman, Bergman, Palmstierna, Schlyter
Tipo	Self-report	Self-report	Self-report
Fonte seminale	Rollnick, S., Heather, N., Gold, R., & Hall, W. (1992). Development of a short 'Readiness to Change' questionnaire for use in brief, opportunistic interventions among excessive drinkers. British Journal of Addiction, 87(5), 743–754.	Cacciola, J. S., Alterman, A. I., Drapkin, M. L., & Valadez, C. (2013). Development and initial validation of the Brief Addiction Monitor (BAM). Journal of Substance Abuse Treatment, 44(3), 256–263.	Berman, A. H., Bergman, H., Palmstierna, T., & Schlyter, F. (2005). Evaluation of the Drug Use Disorder Identification Test (DUDIT) in criminal justice and detoxification settings and in a Swedish population sample. European Addiction Research, 11(1), 22–31.
Alias	RCQ, Readiness to Change Questionnaire	BAM	DUDIT
Correlati	4	4	4
Sintesi	The RCQ is a 12-item self-report instrument designed to assess an individual's stage of change motivation regarding substance use, particularly alcohol use. Developed by Rollnick and colleagues in 1992, it operationalizes the Transtheoretical Model of Change by measuring readiness across the precontemplation, contemplation, and action stages. The RCQ is a brief, cost-effective tool for identifying individuals who are ready to engage in behavior change and for tailoring the intensity and timing of intervention.	The BAM is a 17-item self-report instrument designed to provide rapid, multimodal assessment of substance use, craving, risk factors, protective factors, and psychosocial functioning in individuals receiving addiction treatment. Developed by Cacciola and colleagues in 2013, it serves as an efficient outcome monitoring tool for tracking treatment progress, identifying relapse warning signs, and guiding therapeutic adjustments. The BAM is useful in treatment settings where frequent assessment of multiple domains is needed to optimize care.	The DUDIT is a brief, gender-sensitive screening instrument designed to identify individuals with harmful or hazardous drug use patterns across a wide range of substances. Developed by Berman and colleagues in 2005, it serves as a primary care and public health screening tool to detect drug-related problems before they escalate to dependence or disorder. The DUDIT is freely available and has been validated in multiple languages and settings.